X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
gastroenterology & hepatology (17) 17
index medicus (16) 16
humans (15) 15
male (14) 14
female (13) 13
middle aged (13) 13
infliximab (10) 10
crohn's disease (9) 9
inflammatory bowel disease (9) 9
adult (8) 8
rheumatoid arthritis (7) 7
ulcerative colitis (7) 7
aged (6) 6
crohns-disease (6) 6
treatment outcome (6) 6
validation (6) 6
adalimumab (5) 5
arthritis, rheumatoid - genetics (5) 5
immunology (5) 5
polymorphism, single nucleotide (5) 5
prospective studies (5) 5
risk (5) 5
arthritis, rheumatoid - drug therapy (4) 4
artritis reumatoide (4) 4
association (4) 4
c-reactive protein (4) 4
calprotectin (4) 4
cancer (4) 4
inflammatory-bowel-disease (4) 4
markers (4) 4
multidisciplinary sciences (4) 4
pharmacology & pharmacy (4) 4
polymorphisms (4) 4
research article (4) 4
rheumatology (4) 4
single nucleotide polymorphisms (4) 4
therapy (4) 4
time factors (4) 4
tumor necrosis factor-alpha - antagonists & inhibitors (4) 4
ulcerative-colitis (4) 4
young adult (4) 4
adalimumab - therapeutic use (3) 3
anti-inflammatory agents - therapeutic use (3) 3
antirheumatic agents - therapeutic use (3) 3
arthritis (3) 3
colitis, ulcerative - drug therapy (3) 3
criteria (3) 3
crohn disease - diagnosis (3) 3
crohn disease - drug therapy (3) 3
diagnosis (3) 3
genetic aspects (3) 3
genotype (3) 3
ibd (3) 3
infliximab - therapeutic use (3) 3
medical research (3) 3
medicine, experimental (3) 3
methotrexate (3) 3
oncology (3) 3
patients (3) 3
predictive value of tests (3) 3
quality-of-life (3) 3
recurrence (3) 3
risk factors (3) 3
single-nucleotide polymorphism (3) 3
smoking (3) 3
spain (3) 3
surgery (3) 3
aged, 80 and over (2) 2
analysis (2) 2
anti-tnf (2) 2
anxiety (2) 2
biomarkers (2) 2
carcinoma, hepatocellular - surgery (2) 2
case-control studies (2) 2
clinical medicine (2) 2
clinical-course (2) 2
colitis, ulcerative - diagnosis (2) 2
crohn’s disease (2) 2
cross-sectional studies (2) 2
depression (2) 2
development and progression (2) 2
dosage and administration (2) 2
double-blind (2) 2
drug therapy (2) 2
efficacy (2) 2
endoscopy (2) 2
epidemiology (2) 2
etanercept (2) 2
evidence-based consensus (2) 2
experience (2) 2
feces - chemistry (2) 2
folic acid (2) 2
genes (2) 2
genetic association studies (2) 2
genetic markers (2) 2
genetic polymorphisms (2) 2
genetic predisposition to disease - genetics (2) 2
genetics (2) 2
genetics & heredity (2) 2
genome-wide association (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Oncology, ISSN 0923-7534, 08/2019, Volume 30, Issue 8, pp. 1335 - 1343
Abstract Background Human papillomavirus type 16 (HPV16)-E6 antibodies are detectable in peripheral blood before diagnosis in the majority of HPV16-driven... 
HEAD | HPVC3 | DESIGN | OPCSCC | ONCOLOGY | oropharyngeal squamous cell carcinoma | RISK | COHORT | HUMAN-PAPILLOMAVIRUS | CANCER | Community medicine, Social medicine: 801 | Samfunnsmedisin, sosialmedisin: 801 | VDP | Helsefag: 800 | Health sciences: 800 | Medisinske Fag: 700 | Medical disciplines: 700 | Original
Journal Article
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 08/2019, Volume 50, Issue 3, pp. 278 - 288
Summary Background There are limited data of ustekinumab administered according to the doses recommended in the UNITI studies. Aim To assess the real‐world,... 
Intolerance | Demographics | Endoscopes | Remission | Crohn's disease | Tumor necrosis factor-α | Disease control
Journal Article
PLOS ONE, ISSN 1932-6203, 02/2019, Volume 14, Issue 2, p. e0213073
Journal Article
Pharmacogenomics Journal, ISSN 1470-269X, 04/2016, Volume 16, Issue 2, pp. 137 - 140
Journal Article
Journal of Clinical Gastroenterology, ISSN 0192-0790, 04/2019, Volume 53, Issue 4, pp. 315 - 316
Journal Article
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, ISSN 2050-6406, 07/2018, Volume 6, Issue 6, pp. 952 - 954
Journal Article
JOURNAL OF CLINICAL GASTROENTEROLOGY, ISSN 0192-0790, 03/2018, Volume 52, Issue 3, pp. 229 - 234
Background and Goal: Predicting relapse in inflammatory bowel disease (IBD) patients could allow early changes in therapy. We aimed at evaluating the accuracy... 
PROTEIN | CROHNS-DISEASE | INDUCTION THERAPY | calprotectin | infliximab | ULCERATIVE-COLITIS | MARKERS | RISK | GASTROENTEROLOGY & HEPATOLOGY | inflammatory bowel disease | adalimumab | INFLIXIMAB THERAPY | Inflammatory bowel diseases | Dosage and administration | Diagnosis | Drug therapy | Tumor necrosis factor inhibitors
Journal Article
Digestive Diseases and Sciences, ISSN 0163-2116, 3/2019, Volume 64, Issue 3, pp. 846 - 854
(a) To evaluate the diagnostic accuracy of anti-TNF trough levels to predict mucosal healing in inflammatory bowel disease (IBD); (b) to determine the best... 
Biochemistry, general | Anti-TNF | Oncology | Mucosal healing | Transplant Surgery | Inflammatory bowel disease | Tumor necrosis factor alpha | Medicine & Public Health | Infliximab | Hepatology | Gastroenterology | Trough levels | Adalimumab | Crohn’s disease | Ulcerative colitis | ANTIBODIES | LONG-TERM DURABILITY | CROHNS-DISEASE | ULCERATIVE-COLITIS | Crohn's disease | THERAPY | GASTROENTEROLOGY & HEPATOLOGY | ASSOCIATION | Predictive Value of Tests | Prospective Studies | Biological Products - pharmacokinetics | Humans | Middle Aged | Male | Drug Monitoring - methods | Infliximab - therapeutic use | Colitis, Ulcerative - immunology | Infliximab - pharmacokinetics | Intestinal Mucosa - drug effects | Time Factors | Intestinal Mucosa - immunology | Adalimumab - blood | Adalimumab - pharmacokinetics | Crohn Disease - diagnosis | Tumor Necrosis Factor-alpha - immunology | Anti-Inflammatory Agents - therapeutic use | Adult | Anti-Inflammatory Agents - pharmacokinetics | Female | Colitis, Ulcerative - drug therapy | Infliximab - blood | Wound Healing - drug effects | Biological Products - therapeutic use | Enzyme-Linked Immunosorbent Assay | Endoscopy, Gastrointestinal | Treatment Outcome | Colitis, Ulcerative - blood | Crohn Disease - immunology | Spain | Anti-Inflammatory Agents - blood | Adalimumab - therapeutic use | Colitis, Ulcerative - diagnosis | Crohn Disease - blood | Crohn Disease - drug therapy | Biological Products - blood | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Intestinal Mucosa - pathology | Medicine, Experimental | Medical research | Tumor necrosis factor | Analysis | Hospitals | Colonoscopy | Tumor necrosis factor-TNF | Inflammation | Endoscopy | Clinical medicine | Drug dosages
Journal Article
Pharmacogenomics Journal, ISSN 1470-269X, 07/2018, Volume 18, Issue 4, pp. 539 - 545
Journal Article
Nature Communications, ISSN 2041-1723, 2018, Volume 9, Issue 1, pp. 3927 - 12
Journal Article
Journal Article
Arthritis Research and Therapy, ISSN 1478-6354, 03/2014, Volume 16, Issue 2, pp. R66 - R66
Journal Article
Journal Article